» Articles » PMID: 28463462

Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: the ESC Heart Failure Long-Term Registry

Abstract

Aims: To identify differences in clinical epidemiology, in-hospital management and 1-year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long-Term (ESC-HF-LT) Registry, stratified by clinical profile at admission.

Methods And Results: The ESC-HF-LT Registry is a prospective, observational study collecting hospitalization and 1-year follow-up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.2% presented with pulmonary oedema (PO), 2.9% with cardiogenic shock (CS), 61.1% with decompensated heart failure (DHF), 4.8% with hypertensive heart failure (HT-HF), 3.5% with right heart failure (RHF) and 14.4% with AHF and associated acute coronary syndromes (ACS-HF). The 1-year mortality rate was 28.1% in PO, 54.0% in CS, 27.2% in DHF, 12.8% in HT-HF, 34.0% in RHF and 20.6% in ACS-HF patients. When patients were classified by systolic blood pressure (SBP) at initial presentation, 1-year mortality was 34.8% in patients with SBP <85 mmHg, 29.0% in those with SBP 85-110 mmHg, 21.2% in patients with SBP 110-140 mmHg and 17.4% in those with SBP >140 mmHg. These differences tended to diminish in the months post-discharge, and 1-year mortality for the patients who survived at least 6 months post-discharge did not vary significantly by either clinical profile or SBP classification.

Conclusion: Rates of adverse outcomes in AHF remain high, and substantial differences have been found when patients were stratified by clinical profile or SBP. However, patients who survived at least 6 months post-discharge represent a more homogeneous group and their 1-year outcome is less influenced by clinical profile or SBP at admission.

Citing Articles

Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal.

Manzi L, Buongiorno F, Narciso V, Florimonte D, Forzano I, Castiello D Diagnostics (Basel). 2025; 15(5).

PMID: 40075788 PMC: 11899404. DOI: 10.3390/diagnostics15050540.


Acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography-a subanalysis of the EMPAG-HF trial.

Bogoviku J, Nguyen T, Westphal J, Aftanski P, Moebius-Winkler S, Haertel F Eur Heart J Cardiovasc Pharmacother. 2025; 11(2):190-197.

PMID: 40037298 PMC: 11905748. DOI: 10.1093/ehjcvp/pvaf003.


Impact of iron deficiency on congestion and postdischarge survival in patients recently hospitalised for decompensated heart failure: a multicentre, prospective, observational analysis of the FERIC-RO study.

Margineanu C, Antohi L, Ambrosy A, Bartos D, Collins S, Sinescu C Open Heart. 2025; 12(1).

PMID: 40021206 PMC: 11873344. DOI: 10.1136/openhrt-2024-002851.


Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions.

Parlati A, Madaudo C, Nuzzi V, Manca P, Gentile P, Di Lisi D Card Fail Rev. 2025; 11:e01.

PMID: 39981305 PMC: 11836606. DOI: 10.15420/cfr.2024.32.


Timing of acute decompensated heart failure in patients with heart failure and mildly reduced ejection fraction.

Steffen H, Abel N, Lau F, Schmitt A, Reinhardt M, Akin M Heart Vessels. 2025; .

PMID: 39841200 DOI: 10.1007/s00380-024-02505-3.